5 months ago
PFE
AnalystsRajesh KumarRajesh Kumar's Stock Forecasts
AnalystsRajesh Kumar
Sectors:
Industries:
Analyst Ranking
Top 34%
#1505 out of 4414 analysts
Average Return
+9.82%
Win Rate
67%4 out of 6
Risk vs Reward
Poor
Good
Rajesh Kumar's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Moderna IncMRNA | +35.57% | $121.35 | $78.18 | 2023-07-13 - 2023-11-28 | Sell |
Eli Lilly & CoLLY | +31.62% | $449.46 | $591.60 | 2023-07-13 - 2023-11-28 | Strong Buy |
Bristol Myers Squibb CoBMY | +17.63% | $61.94 | $51.02 | 2023-07-13 - 2023-10-27 | Sell |
Abbvie IncABBV | +1.52% | $136.01 | $138.08 | 2023-07-13 - 2023-11-28 | Strong Buy |
Rajesh Kumar Analyst Color
Get additional color on Rajesh Kumar's coverage of popular stocks
5 months ago
LLY
Rajesh Kumar's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Bristol Myers Squibb CoBMY | 2 | Hold | $53.00 | +8.34% | Upgrades | a month ago |
Moderna IncMRNA | 1 | Sell | $97.00 | +24.07% | Initiates Coverage On | 5 months ago |
Biontech SeBNTX | 1 | Strong Buy | $124.00 | +26.14% | Initiates Coverage On | 5 months ago |
Pfizer IncPFE | 1 | Strong Buy | $50.00 | +68.41% | Initiates Coverage On | 5 months ago |
Merck & Co IncMRK | 1 | Hold | $123.00 | +22.78% | Initiates Coverage On | 5 months ago |
Eli Lilly & CoLLY | 1 | Strong Buy | $560.00 | -5.34% | Initiates Coverage On | 5 months ago |
Abbvie IncABBV | 1 | Strong Buy | $167.00 | +20.94% | Initiates Coverage On | 5 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.